These include semaglutide (Ozempic, Wegovy, Rybelsus), liraglutide (Victoza, Saxenda), dulaglutide (Trulicity), tirzepatide (Mounjaro, Zepbounda dual GIP/GLP-1 agonist), exenatide (Byetta, Bydureon BCise), and lixisenatide (Adlyxin)
retatrutide does not, and the agency warns against peptides sold as 'research chemicals' to bypass medicines law
If symptoms last beyond six weeks or become severe, your healthcare provider may recommend adjusting your dose or trying a different approach
It does not present a GLP-1 as a substitute for thyroid correction
Semaglutide compared to other GLP-1 peptides Semaglutide is not the only GLP-1 receptor agonist available for research
Full article here: To view or add a comment, sign in Around the world, millions of people who live with #obesity are at the point in their weight loss journey where, after successfully accessing and using prescription weight loss medications such as Wegovy or Mounjaro and having reached their initial weight loss goal, ask: what's next